No Data
No Data
CStone Pharmaceuticals Grants Exclusive Promotion Rights for Tumor Drug in China to Jiangsu Hengrui Medicine
Chi-Med-B (02616.HK) signed an exclusive promotion agreement with Jiangsu Hengrui Pharmaceuticals for Tjeenga (Afatinib tablets) in mainland China.
On July 3, Gelunhui announced that it has reached an agreement with Jiangsu Hengrui Pharmaceuticals to grant the exclusive promotion rights of precision therapy drug Tegiwa (Afatibine Tablets) in mainland China. In addition to the exclusive promotion rights granted to Hengrui Pharmaceutical, cornerstone Pharmaceuticals will continue to have the rights to research and development, registration, production, and distribution of Tegiwa in mainland China. With the cornerstone Pharmaceuticals' excellent clinical development capabilities, Tegiwa has become China's first drug for PDGFRA exon 18 mutation type (including D842V mutation) gastrointestinal stromal tumors (GIST).
Express News | CStone Pharmaceuticals - Co and Hengrui Enter Into an Exclusive Promotion Agreement of Ayvakit (Avapritinib Tablets) in Mainland China
Foundation Medicine-B announced that Wing Mui Yee has been nominated as joint company secretary.
Cornerstone Pharmaceutical B (02616) has announced that the company has hired Far East Enterprise Service Group (Hong Kong) Limited to provide secretarial support to the company, and Far East has nominated He Yanqun to serve as the joint company secretary , Company's Hong Kong legal process document agent (legal process document agent who receives legal process documents on behalf of the company in Hong Kong in accordance with Section 622 of the Hong Kong Companies Ordinance Section 16 and receives legal process documents or notices on behalf of the company in Hong Kong in accordance with Rule 19.05 (2) of the Listing Rules of the Hong Kong Stock Exchange, and authorized representative of the company in accordance with Rule 3.05).
CStone Pharmaceuticals - B(02616): Weng Meiyi nominated as Co-Secretary of the Company.
Ji Shi Pharmaceutical Group-B (02616) has announced that the company has hired the Hong Kong-based Far East Enterprise Service Group to publicly offer its services...
CStone Gets Green Light for Local Manufacturing of AYVAKIT in China
No Data